Schulke
Schulke Octenisept Antiseptic Solution Broad Spectrum Skin and Wound Care
Schulke Octenisept Antiseptic Solution Broad Spectrum Skin and Wound Care
无法加载取货服务可用情况
Product Overview
Schulke octenisept is a colourless, ready-to-use antiseptic wound solution manufactured by Schulke and Mayr GmbH (Germany). The formulation combines two synergistic antimicrobial agents: octenidine dihydrochloride, a cationic surfactant-type antiseptic that disrupts bacterial cell membranes, and phenoxyethanol, an aromatic ether alcohol that provides supplementary antimicrobial activity. This dual-agent approach delivers comprehensive antimicrobial coverage against gram-positive and gram-negative bacteria (including MRSA and VRE), fungi (Candida species), enveloped viruses (including HIV, HBV, HCV, and HSV), and mycobacteria.
A distinguishing feature of octenisept is its demonstrated tissue compatibility. Unlike iodine-based or alcohol-based antiseptics, octenisept does not impair fibroblast proliferation, keratinocyte migration, or granulation tissue formation, as confirmed in peer-reviewed studies published in journals including Wound Repair and Regeneration. The solution requires no dilution, contains no colourants or fragrances, and has a neutral pH profile suitable for application to open wounds and intact mucous membranes. Octenisept is classified as a medicinal product under European pharmaceutical regulations and is widely used in hospital wound care, surgical site antisepsis, and outpatient wound management across Europe and Asia. Available in Singapore from EMIS.
Specifications
| Manufacturer | Schulke and Mayr GmbH, Norderstedt, Germany |
| Active Ingredients | Octenidine dihydrochloride 0.1% w/w, Phenoxyethanol 2.0% w/w |
| Excipients | Cocamidopropyl betaine, sodium D-gluconate, glycerol 85%, sodium chloride, sodium hydroxide, purified water |
| Product Form | Ready-to-use aqueous solution |
| Antimicrobial Spectrum | Bactericidal (including MRSA, VRE), fungicidal (Candida spp.), virucidal (HIV, HBV, HCV, HSV) |
| Onset of Action | 60 seconds contact time |
| Age Restriction | None; safe from premature neonates (24th gestational week) through adults |
| Application Sites | Acute and chronic wounds, surgical wounds, burn wounds, mucous membranes |
| Regulatory | CE marked medicinal product; manufactured under ISO 13485 and cGMP standards; HSA Singapore registered |
| Storage | Store below 25 degrees C; protect from frost; shelf life 3 years unopened |
Clinical Indications
- Antiseptic wound irrigation and decontamination of acute traumatic wounds (lacerations, abrasions, puncture wounds)
- Chronic wound management including venous leg ulcers, pressure ulcers (decubitus), and diabetic foot ulcers
- Pre-operative and post-operative surgical site antisepsis to reduce surgical site infection (SSI) risk
- Burn wound antisepsis for partial-thickness and full-thickness thermal injuries
- Mucous membrane antisepsis including oral, nasal, and genital mucosal applications
- MRSA decolonisation protocols in combination with octenisan wash lotion as per hospital infection control guidelines
Frequently Asked Questions
Q: How does octenidine compare to chlorhexidine and povidone-iodine for wound antisepsis?
A: Octenidine demonstrates comparable or superior antimicrobial efficacy to chlorhexidine and povidone-iodine while offering significantly better tissue compatibility. A systematic review published in the Journal of Hospital Infection found that octenidine-based antiseptics achieve equivalent MRSA decolonisation rates to chlorhexidine without the associated risks of anaphylaxis or ototoxicity. Unlike povidone-iodine, octenisept does not inhibit fibroblast function or delay wound healing, making it preferable for chronic wound management per European Wound Management Association (EWMA) guidelines.
Q: Is octenisept safe for use in neonates and paediatric patients?
A: Yes. Octenisept has an established safety profile in neonatal care, with clinical use documented in premature infants from the 24th week of gestation. The product does not contain iodine (which poses thyroid disruption risk in neonates) or alcohol (which can cause skin burns in premature infants). Pharmacokinetic studies confirm minimal systemic absorption of octenidine through intact or compromised skin.
Q: What is the correct application technique for wound antisepsis?
A: Spray or irrigate the wound with octenisept solution, ensuring complete coverage of the wound bed and margins. Allow a minimum contact time of 1 to 2 minutes before applying a wound dressing. For heavily contaminated wounds, the solution may be left in contact for up to 2 minutes to ensure thorough decontamination. Do not inject into tissue under pressure, as this may cause tissue necrosis in enclosed spaces.
Q: Can octenisept be used for oral and mucosal antisepsis?
A: Yes. Octenisept is approved for mucous membrane application and is used in dental and oral surgery for pre-procedural oral rinse protocols. It is also indicated for genital mucosal antisepsis. The neutral pH and absence of alcohol make it well-tolerated on sensitive mucosal surfaces compared to alcohol-based mouthwashes or antiseptics.
Q: Where can I purchase octenisept in Singapore?
A: Schulke octenisept antiseptic solution is available in Singapore through EMIS (Essential Medical International Supplies Pte Ltd) at emis.asia. EMIS is an authorised distributor of Schulke wound care and infection control products in Singapore. The product is registered with the Health Sciences Authority (HSA) Singapore and supplied with full regulatory traceability. Suitable for hospitals, clinics, home wound care, and professional first aid applications.
分享
